Clicky

Roche Holding AG(ROGN)

Description: Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.


Keywords: Pharmaceutical Cancer Pharmaceutical Products Disease Diabetes Solid Tumors Oncology Hepatitis Transplantation Neurological Disorders Anemia Hemophilia Inflammatory Roche Respiratory Disorders Digital Health Solutions Autoimmune

Home Page: www.roche.com

Grenzacherstrasse 124
Basel, 4058
Switzerland
Phone: 41 61 688 11 11


Officers

Name Title
Dr. Severin Schwan Ph.D. Executive Chairman
Dr. Thomas Schinecker Chief Executive Officer
Dr. Alan Hippe Chief Financial & Information Officer
Dr. Bruno Eschli Head of Investor Relations
Ms. Claudia Bockstiegel General Counsel
Ms. Pascale Schmidt Chief Compliance Officer
Ms. Barbara Schadler Head of Group Communications
Ms. Cristina A. Wilbur Chief People Officer
Dr. Nicolas Dunant Head of Group Media Relations
Mr. Boris L. Zaitra Head of Corporate Business Development

Exchange: MX

Country: MX : Mexico

Currency: Mexican Peso (₱)

Forward PE: 12.21
Trailing PE: 19.4153
Price-to-Book MRQ: 7.0707
Price-to-Sales TTM: 78.4736
IPO Date:
Fiscal Year End: December
Full Time Employees: 103605
Back to stocks